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MD force ﬁeldMembrane-active antimicrobial peptides (AMPs) are challenging to study experimentally, but relatively easy to
investigate usingmolecular dynamics (MD) computer simulations. For this reason, a large number ofMD studies
of AMPs have been reported over recent years. Yet relatively little effort has focused on the validity of such sim-
ulations. Are these results reliable, and do they agreewithwhat is known experimentally? Andhowmuchmean-
ingful information can be obtained? To answer these questions, we demonstrate here some of the requirements
and limitations of running MD simulations for several common AMPs: PGLa, melittin, maculatin and BP100. The
two most important ﬁndings are: (a) simulation results depend strongly on force ﬁeld parameters, making ex-
perimental veriﬁcation of the simulations obligatory, and (b) slow orientational and conformational ﬂuctuations
mean thatmuch longer sampling timescales (multi-μs) are needed if quantitative agreement between simulation
averages and experimental data is to be achieved. This article is part of a Special Issue entitled: Interfacially Active
Peptides and Proteins. Guest Editors: William C. Wimley and Kalina Hristova.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Membrane-active antimicrobial peptides (AMPs) are found in many
organisms and are currently of major pharmaceutical interest as a
potential source of new antibiotics against increasingly common
multiresistant pathogens [1,2]. Most of these peptides kill bacteria by
physically interacting with and disrupting their cell membranes. The
exact molecular mechanism concerned is not fully understood at pres-
ent, with a large number of models proposed over the last decades [3].
Because it is experimentally challenging to study these highly mobile
peptides in membranes, molecular dynamics (MD) simulations have
been proposed as an alternative. Over the last years, countless such sim-
ulations have been presented on a large number of AMPs and related
cell-penetrating peptides [4,5]. Because the results of these simulations
have been almost as diverse as the mechanisms proposed, the question
arises as to how accurate MD actually is and whether these results can
be trusted. Interestingly, there is relatively little information on thislly Active Peptides and Proteins.
sjtu.edu.cn (J.P. Ulmschneider).issue to date. Most MD studies of membrane-active peptides lack any
but the most basic veriﬁcation versus experimental data, so the results
have to be taken ‘as is’. Previously, in the absence of any quantitative ex-
perimental measurements, this situation may have been acceptable.
However, considerable progress has beenmade in recent years to obtain
highly accurate information on AMPs and other membrane-active pep-
tides from methods such as oriented circular dichroism (OCD) [6] and
solid state NMR [7,8]. Many of these experiments unfortunately say lit-
tle about the transition state for pore formation and only give informa-
tion on the more populous ground states. However, they nevertheless
provide a valuable benchmark for comparison to MD simulations.
In this short report, we highlight some of the problems of MD simu-
lations of AMPs and how to avoid them. In particular, we show that the
results depend vitally on a correct force ﬁeld parameter balance and on
achieving long enough sampling times. Otherwise, MD can yield results
that contradict what has been measured experimentally. We do not
perform a generic force ﬁeld comparison here, but focus exclusively
on the subject of peptides in membranes. Ultimately, only a combined
experimental/computational approachwill allow identifying the specif-
ic physicochemical properties that lead to antimicrobial function, and
thus allow to predict and to improve the therapeutic impact of new
AMP sequences.
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All simulations were performed and analyzed using GROMACS
version 4.6.3 (www.gromacs.org) [9] and HIPPO beta (www.
biowerkzeug.com), using the CHARMM27 force ﬁeld [10], the OPLS-
AA force ﬁeld [11], the GROMOS96-53a6 force ﬁeld [12], and the TIP3P
water [13]. CHARMM36 all-atom lipid parameters were used [14], and
united atom lipid parameters were taken from Ulmschneider and
Ulmschneider [15], and Berger et al. [16]. Electrostatic interactions
were computed using particle-mesh-Ewald (PME), and a cut-off of
10 Å was used for the van der Waals interactions. Bonds involving hy-
drogen atoms were restrained using LINCS [17]. Simulations were run
with a 2 fs time-step, and neighbor lists were updated every 5 steps.
All simulationswere performed in the NPT ensemble, withwater, lipids,
and the protein coupled separately to a heat bath with T = 35 °C and a
time constant τT= 0.1 ps usingweak temperature coupling [18]. Atmo-
spheric pressure of 1 bar was maintained using weak semi-isotropic
pressure coupling with compressibility κz = κxy = 4.6 · 10−5 bar−1
and time constant τP = 1 ps [19]. All peptides were constructed asFig. 1. Twoexamples of our rapid bilayer insertion simulations, for PGLa (top) and BP100 (bottom
The peptides are helically restrained, and the simulation temperature is increased to 90 °C. Rap
states, with the charged sidechains pointing upwards into the bilayer interface. No further trans
point for subsequent simulations at room temperature. The approach is completely unbiased, a
peptides initially point their charged sidechains towards the membrane (PGLa simulation, greeideal α-helices and inserted into a preformed lipid bilayer made up of
58 DMPC lipids and ~30 water molecules per lipids, as described previ-
ously [20]. The 1 μs PGLa dimer simulation at 60 °C was performed on
the Antonmachine at Pittsburg Supercomputing Center, all other simu-
lations (cumulative time of 37 μs) were performed on conventional
clusters. For all quantities, the standard deviation of the mean was cal-
culated by block averaging over 10 blocks, and these are plotted as
error bars.
To compare with solid state NMR data of a selectively labeled pep-
tide embedded in a macroscopically oriented membrane sample, the
corresponding 2H quadrupolar splitting or 19F dipolar coupling was ob-
tained from the simulations by calculating the local bond order param-
eter SCD:
SCD ¼ 1=2 3 cos2θ−1
D E
:
Here, the angle θ is between the Cα and Cβ bonds of the labeled res-
idue and the membrane normal, which is parallel to the magnetic ﬁeld
(z-direction).). All peptides are initially placed into the solvent, ~40 Å away from themembrane center.
id insertion is seen during the ﬁrst 2 ns, and the peptides adopt stable inserted surface (S)
itions occur. Theﬁnal state of the high-temperature simulations is then used as the starting
nd always yields the same S-state: for example, it plays no role whether the amphipathic
n residues), or away (BP100 simulation, blue residues).
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from
Δνq ¼ 3=2ð ÞQCCSCD ¼ 42kHz SCD
where the quadrupolar coupling constant QCC = 167 kHz for a C–D
bond [21], and a factor 1/3 comes from the fast rotation of the CD3-
group around the Cα–Cβ bond. The 19F-19F dipolar coupling of a CF3-Fig. 2. Secondary structure of two antimicrobial peptides, PGLa (top) and melittin (bottom), in
andwere run using twodifferent forceﬁelds. The overall helicity (left panels) and thehelicity pe
the peptides are substantially less stable than with CHARMM and all-atom lipids (red curves), a
slow process, visible only on the μs time scale: the ﬁrst unfolding in the central stretch of PGLa
needs to be captured to model the complex interactions of amphipathic peptides in the chargegroup (as for example in CF3-Bpg, 3-(triﬂuoromethyl)-L-bicyclopent-
[1.1.1]-1-ylglycine [22]) was obtained from
Δd ¼ 17:0kHz SCD
where the maximum dipolar coupling between 19F atoms within the
CF3-group used here is an average value obtained from various CF3-
labeled amino acids [23,24]. The quadrupolar splittings and dipolarthe surface-bound (S-)state. The MD simulations started from fullα-helices in the S-state
r residue (right panels) are shown.WhenusingOPLSwith united atom lipids (blue curves),
n effect that was not previously observed for many hydrophobic sequences. Unfolding is a
occurs only after 600 ns (gray shaded area). The results reveal the subtle equilibrium that
d and complex bilayer interfaces.
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ﬁtted with a theoretical model using a procedure described previously
[25].Fig. 3. Solid state NMR is an ideal method to validate the results of MD simulations of
AMPs. (A) Orientational histogram (tilt angle τ and azimuthal rotation angle ρ) of PGLa
in the S-state averaged over a 3 μs MD run. The average is very close to the NMR results
(indicated by a red dot) of τ≈ 95° and ρ≈ 116°. (B) Quadrupolar splittings |Δvq| of all res-
idues averaged over the MD simulations (red squares), as compared to solid state NMR
measurements of Ala-d3-labeled PGLa in a DMPC bilayer at P/L = 1:200 (gray triangles)
[35]. The curves show the best ﬁt to a helical wave. The unfolding of PGLa in the OPLS sim-
ulation results in a large spread of |Δvq| values, and thematch to NMR is poor. A ﬁt close to
the experimental results is obtained for the CHARMM force ﬁeld in which the peptide re-
mains folded. These results suggest that PGLa is fully helical, and that the unfolding ob-
served in MD is erroneous. Error bars σ|Δvq|mean are obtained from block averaging.3. Results
3.1. Monomeric surface-bound state
We ﬁrst investigated the equilibrium of monomeric AMPs at low
peptide-to-lipid ratios (P/L), underwhich the peptides are not expected
to exist in any oligomeric state. Given their amphipathic structure, there
is usually only one surface-bound (S-)state, where the peptide is
inserted with its axis perpendicular to the membrane normal and the
charged sidechains pointing upward into the bilayer interface. This
state can be rapidly predicted by using unbiased insertion simulations
at elevated temperatures (Fig. 1) [20]. The last structure from these sim-
ulations is then used as the starting point for the equilibrium simula-
tions at physiological temperature. Fig. 2 shows the results for two
representative peptides, PGLa from the African frog Xenopus laevis
(GMASKAGAIAGKIAKVALKAL-NH2) [26–28] and melittin (GIGA
VLKVLTTGLPALISWIKRKRQQ). Starting from a completely helical struc-
ture, both were simulated at the experimental temperature (T= 35 °C)
for 2–3 μs, using two different protein force ﬁelds (OPLS vs. CHARMM)
with different lipid parameters (united atom lipids vs. all-atom lipids).
The outcome of these simulations is quite different: in general,
the CHARMM/AA-lipid (II) results are much more helical than the
OPLS/UA-lipid runs (I). For PGLa, the CHARMM simulation shows a
full α-helix, but only ~73% helicity in the OPLS simulation. Several
perturbed helical states can be seen (top panels), indicating that the
helix is destabilized at the two glycine positions G7 and G11, where
the backbone hydrogen bonds are open to polar interfacial groups and
water molecules.
The difference is even more dramatic for melittin. Due to a central
proline, both simulations show a pronounced kink in the middle of
the peptide, and an unstructured (highly charged) C-terminus. Howev-
er, for OPLS/UA-lipids, there is a slow unfolding of the entire N-terminal
half over the course of 2 μs, whereas the CHARMM/AA-lipid simulation
predicts a much more helical structure (78%). For both peptides,
unfolding is thus a slow process. For example, the ﬁrst central backbone
hydrogen bond in PGLa breaks after 600 ns (OPLS/UA-lipids). Unfolding
of melittin takes the full 2 μs. Hence, these long-scale transitions have
not been observed in many earlier simulation studies of AMPs where
timescales of only 100–200 ns were used. Of course, there is the possi-
bility that ultimately, also the CHARMM/AA-lipid simulation could
yield unfolded structures, only taking much longer to do so. We have
shown however, that no unfolding of melittin is observed during 17 μs
in such simulations [29]. We thus consider that the CHARMM/AA-lipid
results converged.
So which simulation result is correct? A good way to answer this
question is to compare theMDmodels with experimental data. Numer-
ous techniques have been used to determine the structure of melittin in
the membrane interface, suggesting 70–85% average helicity [30–34].
The unfolding observed in Fig. 2 is inconsistent with this. For PGLa,
very accurate information comes from solid state NMR. Measurements
from Ala-d3-labeled PGLa in DMPC at P/L = 1:200 [35] are shown in
Fig. 3. These experiments suggest an almost fully folded peptide, with
some instability only in the C-terminal region of PGLa (residues A17 to
A20), butwith an ideal helix from residues A6 to V16 [35]. A comparison
of the simulated and experimental quadrupolar splittings |Δvq| reveals
that the more helical simulations ﬁt much better to the experiments
(Fig. 3). Both the helix tilt and the azimuthal rotation angles of
the CHARMM/AA-lipid simulations are very close to the NMR results
(indicated by a red dot). Overall, this comparison strongly suggests
that the unfolding observed for PGLa in MD using OPLS/UA-lipids is er-
roneous, similar to the melittin result.3.2. Time-scale of folding transitions
Ideally, we could compare force ﬁeld parameters conveniently the
way we have just shown. However, fully folded α-helices were the
starting structures in these simulations. In contrast, when the simula-
tions are initiated from coiled or partly folded conformations, the
times to reach equilibrium can be very long. We illustrate this for the
case of maculatin 1.1 (GLFGVLAKVAAHVVPAIAEHF-NH2), a cationic
AMP isolated from the skin secretions of the frog species Litoria
genimaculata [36]. Two peptides were studied, with one placed in each
bilayer leaﬂet, and starting from different coiled and partially folded
α-helices. In addition to the two force ﬁelds used above, we also
added simulations using GROMOS96-53a6/UA-lipids. The results are
2284 Y. Wang et al. / Biochimica et Biophysica Acta 1838 (2014) 2280–2288shown in Fig. 4. Clearly, the simulations are not yet converged on the 2
μs timescale, with the two peptides sampling widely different confor-
mations in each bilayer leaﬂet. The results also depend strongly on the
choice of force ﬁeld. Unless the two peptides in each simulation reach
the same equilibrium, it is unlikely that reliable results can be extracted
from such simulations, nor can a decision be made as to which force
ﬁeld performs best. It is obvious that modeling interfacial folding equi-
libria of AMPs require much longer sampling times than 2 μs, and that
simulations shorter than this (unfortunately the case for most studies)
appear to be unreliable.
3.3. Long-scale transitions
If a parameter set is found that accurately reproduces the average
secondary structure of an AMP, there will still be long-scale transitionsFig. 4.Helicity of monomeric surface-bound maculatin 1.1 observed in MD simulations in
POPC bilayers at 35 °C. Three different force ﬁelds were used: CHARMM/AA-lipids (A),
OPLS-AA/UA-lipids (B), and GROMOS96-53a6/UA-lipids (C). The simulations started
from a mostly folded (red) and one coiled peptide structure (blue). Results vary signiﬁ-
cantly both between the two peptides and between the different force ﬁelds. For a reliable
estimate of the helicity of maculatin, much longer simulations would be needed.in its orientation in themembrane, some ofwhich are related to speciﬁc
backbone hydrogen bonds breaking or forming on the multi-μs time-
scale. We can illustrate this using the particularly intriguing peptide
BP100, a multifunctional membrane-active sequence with a high anti-
microbial activity [37] and an excellent cell-penetrating activity [38]. It
carries 6 positive charges and forms an amphiphilic α-helix, similar to
other AMPs. However, BP100 is very short, with only 11 amino acids
(KKLFKKILKYL-NH2), and thus cannot form membrane-spanning pores
as proposed for longer peptides. We performed MD simulation of
BP100 in DMPC bilayers at 35 °C in the surface-bound S-state (Fig. 5),
using the CHARMM/AA-lipid force ﬁeld. The peptide started from a
fully helical conformation, an assumption supported by circular dichro-
ism (CD) data that suggests BP100 is predominantly α-helical (61%) in
the presence of DMPC/DPMG (3:1) [39]. One of the ﬁrst surprises was
that the peptide can tilt away far from the S-state, by deeply inserting
the C-terminus, with a tilt angle of τ N 150°. The tilt is alsowidely spread
(±14°), indicating that the peptide is highly mobile. Over 1.5 μs, an av-
erage of τ= 109° was obtained, which is about 40° less than the nom-
inal best-ﬁt tilt angle extracted from the 19F-NMR data (Fig. 6), but in
good agreement with the range around τ≈ 110° as concluded from a
combined 19F-NMR/15N-NMR/OCD analysis [39]. In theMD simulations,
however, the N-terminal lysines unfolded after 1.5 μs, resulting in a pro-
nounced downshift of the tilt angle. For the remaining simulation time,Fig. 5.Orientation and structures observed in a 8 μsMD simulation of BP100 in the S-state of
BP100 in a DMPC bilayer at 35 °C. The peptide is initially fully helical. Long-scale transitions
of peptide tilt angle are visible, occurring on timescales N1 μs. After 1.5 μs, the N-terminus
unfolds, resulting in a signiﬁcantly reduced tilt angle. Refolding of the N-terminus occurs
only very rarely, and it remains on average unfolded (lower panel: average helicity per
residue). The equilibriumorientation of BP100 is almostﬂat,with τ=97°±4°, but strongly
tilted orientations (up to 130°) also occur frequently.
Fig. 7. Example of a putative dimeric structure of PGLa. (A) This particular antiparallel ar-
rangement is stabilized by a dimerization interface made up of the small central residues
G11 and G7 (green) and A10 and A14 (purple), resulting in a highly packed, interlocked
dimer. (B) Helix–helix center of mass distance as a function of simulation time during
MD simulations of the PGLa dimer structure in DMPC bilayers at 35 °C. The stability of
the dimer on the μs time-scale depends strongly on the chosen force ﬁeld parameters. A
breakup of the dimer is observed for OPLS/UA-lipids after 250 ns, whereas the dimer is
completely stable in the CHARMM/AA-lipid runs.
Fig. 6. Time-averaged orientation of BP100 in a DMPC bilayer in the S-state. (A) 2D histo-
grams as a function of the peptide tilt (τ) and azimuthal rotation (ρ) angles. The rotation
angle ρ is deﬁnedwith respect to the Cα atomon Lys 1. The left panel shows the results for
theﬁrst 1.5 μs, before theN-terminus starts to unfold. The right panel shows the remaining
6.5 μs. The downshift of the tilt angle after 1.5 μs can be seen,while the rotation angle does
not change much (insets: histograms of τ and ρ averaged over the simulations, 0–1.5 μs
in black, N1.5 μs in red). The nominal best-ﬁt 19F-NMR results are indicated by a red dot
(τ≈ 70° and ρ≈−10°). (B) Dipolar couplings of all residues averaged over the MD sim-
ulations (red squares), as compared to couplings from 19F-NMR data of BP100 in DMPC/
DMPG (3:1) bilayers at P/L = 1:100 (gray triangles) [39]. The curves show the best ﬁt
to a helical wave. The corresponding reduction in tilt angle results in a markedly better
match of the MD results (right panel) to the NMR data compared to the ﬁrst 1.5 μs (left
panel), although there is still a 25° tilt angle difference between MD and NMR. These re-
sults show how long-scale orientational transitions strongly inﬂuence the accuracy of
the agreement between simulation and experiment. Error bars σΔdmean are obtained from
block averaging.
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not allow the peptide to tilt as strongly as before. The average helicity
over the second phase was 81%, a bit more than for the wild type pep-
tide, but right in the range of the 77–87% obtained by CD for the CF3-
Bpg labeled analogs used in the NMR studies [39]. The unfolding transi-
tion is found to be crucial in improving the accuracy of the simulation
results when compared to NMR, as can be seen in Fig. 6. The high tilt
angle in the ﬁrst 1.5 μs is clearly an artifact of the initial simulation con-
ditions (e.g. full helix). In the lower panels of Fig. 6, we directly compare
the dipolar couplings obtained from MD and those from 19F-NMR data
of BP100 in DMPC/DMPG (3:1) bilayers at P/L = 1:100. The match in
the second simulation phase N1.5 μs is signiﬁcantly better than the
one for the ﬁrst 1.5 μs. These results demonstrate that very long sam-
pling times are essential for a quantitative match between simulations
and experiments. Otherwise, the results from MD can strongly depend
on initial conditions (here: initial full helix). But even after the unfolding
transition at 1.5 μs, the tilt angle of BP100 is seen to undergo large tran-
sitions on the time-scale ofmanymicroseconds (Fig. 5),which alsohas a
pronounced effect on the solid state NMR data analysis [40]. It is thus
unlikely that MD simulations shorter than this are suitable for reliable
simulation averages to be compared to experiments, in which the sam-
pling time is many orders of magnitude longer still.
3.4. Aggregates and dimers at higher P/L
So farwe have looked only at the equilibria of AMPs at low P/L ratios
where we assumed the peptides to be surface-bound andmonomeric. Ifwe desire to study the various unknown surface-bound aggregates and
possibly inserted transmembrane pores formed by these peptides at
high P/L, then the accuracy of the simulation model becomes even
more important. Unfortunately, there is very little structural experi-
mental data available to guide an MD simulator in this case.
To illustrate the challenge to accurately model interfacial aggrega-
tion of AMPs, we have chosen the example of a putative dimer of PGLa
(Fig. 7). This structure was suggested by recent solid-state 2H-, 15N-
and 19F-NMRmeasurements of PGLa in DMPC. Upon an increase of pep-
tide concentration to P/L = 1:100–1:20 a transition occurred from the
monomeric S-state to a tilted “T-state”, with τ ≈ 127° [25,35,41,42].
Self-assembly of peptides to dimers is likely the reason for the stepwise
change of the NMR splittings with peptide concentration [43]. The T-
state was suggested to be an antiparallel dimer due to the presence of
a single set of NMR splittings indicating that this dimer must be
rotationally symmetric with respect to the membrane normal [41].
Loss of helicity was not observed.
Because ab-initio prediction of such aggregates probably requires
milliseconds of simulation time, we chose a different path and assem-
bled candidate dimers using a more rapid protocol in which initial di-
mers were constructed and picked only if they remained intact
(Fig. S1) [20]. The antiparallel arrangement shown in Fig. 7 was found
in this way. How reliable is this structure? It can be seen that different
force ﬁelds again lead to very different results. While the OPLS/UA-
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disintegrated over the course of the following 4 μs, in a stepwise
fashion that also included signiﬁcant unfolding. In contrast, the
dimer was found to be entirely stable in the CHARMM/AA-lipid
simulations.
In fact the CHARMM/AA-lipid simulations predict the dimer to be so
stable that it is essentially impossible to break. This is illustrated in Fig. 8.
We placed 4 dimers in a large DMPC lipid bilayer (288 lipids) and
increased the simulation temperature to 60 °C. There was a rapid
2-dimensional diffusion of the dimers in their bilayer leaﬂet, and fast
rotational averaging occurred. However, no dimer broke apart or un-
folded. No further surface aggregation was seen; in fact the dimers
appeared to avoid each other, with only some occasional close encoun-
ters involving the termini. The formation of pores was not observed
over the 1 μs of simulation time.4. Discussion
From our results, there are two clear lessons for MD simulations of
AMPs: (a) the simulation results depend strongly on force ﬁeld param-
eters, making experimental veriﬁcation of the simulations obligatory,
and (b) slow orientational and conformational ﬂuctuations mean that
very long sampling timescales (multi-μs) are needed if quantitative
agreement between simulation averages and experimental data is to
be achieved. Apparently, the challenge to accurately model AMPs is al-
ready tough for the simplest case of monomeric surface-bound (S)
states at low peptide-to-lipid ratios. This means that the modeling of
much more complex phenomena, such as aggregation and pore forma-
tion at high P/L, is unlikely to succeed unless the underlying models
have been properly tested and tuned.Fig. 8.MD simulation ofmultiple PGLa antiparallel dimers in a DMPCbilayer. The temperaturew
are completely stable (using the CHARMM/AA-lipidmethod), and no breakup or unfolding is ob
normal) are observed. However, aggregation does not occur, because either the temperature isIt is not clear what causes the large differences observed in our
simulation studies. The partial charges of protein backbone groups
of OPLS, CHARMM and GROMOS are nearly identical and should
lead to the same strength of hydrogen bonds and thus secondary
structure. Some incongruencies might be attributed to differences
in backbone torsion angles. However, the most obvious culprit is
the balance between the lipid and protein force ﬁelds. We have sim-
ulated OPLS and GROMOS with united atom lipids, but CHARMM
with all-atom lipids. This is a major difference. Not only do united
atom lipids allow for more protein ﬂexibility – and thus unfolding –
but there is also a difference in how deep water molecules pene-
trate into the interface. The interactions between peptide and lipid
atoms in the polar lipid phosphocholine headgroups, as well as the
glycerol linker and ester groups, are highly complex and have been
the topic of numerous studies. A change from all-atom to united
atom lipids almost certainly will shift this balance. Thus, the proba-
ble cause for the differences in structural stability of the peptides is
not the protein force ﬁeld per se, but rather the imbalance between
lipid and protein force ﬁelds. Unfortunately, no OPLS or GROMOS
all-atom lipid parameters for DMPC/POPC are available to test this
assumption. If correct, this dilemma would affect most of the pub-
lished simulations of AMPs, which have overwhelmingly been
based on united atom lipid force ﬁelds (for speed). More studies
are clearly necessary to investigate these issues.
Our results mirror earlier observations on hydrophobic WALP pep-
tides (which are of similar length to AMPs) in lipid bilayers, which
had shown some unnatural helical unfolding on the μs-scale [15,
44–46]. In addition to forceﬁeld issues, it has also been recently demon-
strated that the outcome of simulations of membrane-active peptides is
greatly inﬂuenced by the choice of the electrostatic long-range models,
and by the inclusion or omission of counter-ions [4]. Thus, great careas raised to 60 °C to increase the speed of orientational sampling. Even at 60 °C, the dimers
served over 1 μs. Rapid translational drift and rotational averaging (around themembrane
too high or the timescale is too short.
2287Y. Wang et al. / Biochimica et Biophysica Acta 1838 (2014) 2280–2288must be taken before drawing conclusions from MD simulations of
AMPs.
Our second observation is that short MD simulations (t b 1–2 μs)
are – at best – qualitative. Major transitions in the backbone, sidechain
orientations and the overall tilt and azimuthal rotation angles occur
on timescales of many μs. A particular illustration of this point was
shown in a recently very long 17 μs MD study of melittin in DOPC bilay-
ers [29]. Two peptides were placed on the bilayer interface, one in each
leaﬂet. In one peptide a sudden folding transition occurred at 8 μs, in-
creasing its helicity from 75 to 89% and resulting in very different dom-
inating conformational clusters. Thus, it is still challenging to obtain
reliable equilibria fromMD, unless the simulations becomemuch longer
than the timescale of these sudden events. The biophysical experiments
are obviously onmuch longer timescales, so it is clear that only for very
long multi-μs runs there is a chance of a quantitative agreement. Fortu-
nately, much longer simulations can now be run routinely on high per-
formance clusters, or on special hardware such as Anton.
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